Showing results (201-210 of 296) with videos related to
Sort By:
Pageof 30
British Journal of Haematology|March 25, 2017
Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibitionChun-Yu Liu, Feng-Shu Hsieh, Pei-Yi Chu, et al.Journal of Clinical Apheresis|February 13, 2007
A new model for predicting the timing of leukapheresis on the basis of CD34+ cell and hematopoietic progenitor cell levelsHao-Wei Teng, Liang-Tsai Hsiao, Shu-Chou Chaou, et al.Journal of Cancer|July 31, 2025
Impact of PIK3CA Mutations on the Clinical Benefits of CDK 4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer: An Updated Pairwise and Network Meta-AnalysisSheng-Fan Wang, Chian-Ying Chou, Yi-Wen Chao, et al.Clinical and Experimental Medicine|August 12, 2024
Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian populationBo-Fang Chen, Yi-Fang Tsai, Ta-Chung Chao, et al.Leukemia & Lymphoma|November 9, 2010
Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experienceHan-Nan Lin, Chun-Yu Liu, Ying-Chung Hong, et al.European Journal of Haematology|January 4, 2013
Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhageYi-Sheng Chou, Jyh-Pyng Gau, Yuan-Bin Yu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis BYi-Hsiang Huang, Liang-Tsai Hsiao, Ying-Chung Hong, et al.Current Medical Research and Opinion|July 19, 2017
Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinibPo-Shen Ko, Yuan-Bin Yu, Yao-Chung Liu, et al.The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 8, 2018
Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: A cohort study in a high endemic areaYao-Chung Liu, Chi-Jung Wu, Po-Shen Ko, et al.Pageof 30